Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
stocks
Ask the analyst: Are Qantas shares a value trap?
stocks
Palantir earnings: Blockbuster growth amid high expectations
stocks
ResMed earnings: Solid showing from ASX healthcare winner
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,111.10 | 82.30 | 0.91% |
CAC 40 | 7,633.81 | 12.77 | 0.17% |
DAX 40 | 23,903.35 | 57.28 | 0.24% |
Dow JONES (US) | 44,167.99 | 56.25 | 0.13% |
FTSE 100 | 9,161.07 | 18.34 | 0.20% |
HKSE | 24,910.63 | 8.10 | 0.03% |
NASDAQ | 21,012.30 | 95.75 | 0.46% |
Nikkei 225 | 40,794.86 | 245.32 | 0.60% |
NZX 50 Index | 12,880.16 | 3.12 | 0.02% |
S&P 500 | 6,320.64 | 21.45 | 0.34% |
S&P/ASX 200 | 8,843.70 | 73.30 | 0.84% |
SSE Composite Index | 3,633.99 | 16.40 | 0.45% |